Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 244 citing articles:

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Mark Yarchoan, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 294-311
Closed Access | Times Cited: 106
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
Kang Wang, Yan‐Jun Xiang, Hongming Yu, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 708-715
Closed Access | Times Cited: 52
Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives
Ke-Yu Shen, Ying Zhu, Sun‐Zhe Xie, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Bruno Sangro, Lorenza Rimassa, Maxime Ronot, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 30
Updates on Systemic Therapy for Hepatocellular Carcinoma
Panagiotis Ntellas, Ian Chau
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 26
Targeting the tumour vasculature: from vessel destruction to promotion
Sophie Guelfi, Kairbaan Hodivala‐Dilke, Gabriele Bergers
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 655-675
Closed Access | Times Cited: 26
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal
Franco Trevisani, Alessandro Vitale, Masatoshi Kudo, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 4, pp. 661-669
Closed Access | Times Cited: 25
Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice
Giuseppe Cabibbo, Ciro Celsa, Lorenza Rimassa, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 6, pp. 957-966
Open Access | Times Cited: 21
British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults
Abid Suddle, Helen L. Reeves, Richard Hubner, et al.
Gut (2024) Vol. 73, Iss. 8, pp. 1235-1268
Open Access | Times Cited: 18
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Arndt Vogel, S.L. Chan, Laura A. Dawson, et al.
Annals of Oncology (2025)
Closed Access | Times Cited: 2
Cancer stem cells and niches: challenges in immunotherapy resistance
Yonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma
Mir Lim, Magdalena Espinoza, Yi‐Hsiang Huang, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2461735-e2461735
Open Access | Times Cited: 2
Immunotherapy for hepatocellular carcinoma: The next evolution in expanding access to liver transplantation
Michael Li, Sherrie Bhoori, Neil Mehta, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 4, pp. 743-755
Closed Access | Times Cited: 16
Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges
Shunzhen Zheng, Siew Wee Chan, Fei Liu, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1582-1582
Open Access | Times Cited: 15
The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications
Kaina Chen, Timothy Wai Ho Shuen, Pierce K. H. Chow
British Journal of Cancer (2024) Vol. 131, Iss. 3, pp. 420-429
Open Access | Times Cited: 15
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives
Amy J. Wisdom, Christopher A. Barker, Joe Y. Chang, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1404-1421
Closed Access | Times Cited: 13
Role of microvascular invasion in early recurrence of hepatocellular carcinoma after liver resection: A literature review
Zhihong Zhang, Chuang Jiang, Zeyuan Qiang, et al.
Asian Journal of Surgery (2024) Vol. 47, Iss. 5, pp. 2138-2143
Open Access | Times Cited: 13
Signaling pathways in liver cancer: pathogenesis and targeted therapy
Yangtao Xue, Yeling Ruan, Yali Wang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 13
Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities
Ming‐Da Wang, Xuejun Xu, Ke‐Chun Wang, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2159-2169
Open Access | Times Cited: 12
Immunotherapy for hepatocellular carcinoma
Alexa Childs, Gloryanne Aidoo-Micah, Mala K. Maini, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101130-101130
Closed Access | Times Cited: 12
Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resection
Carla Fuster, Ezequiel Mauro, Joana Ferrer, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 995-1004
Closed Access | Times Cited: 12
Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments
Claudia Campani, Sandrine Imbeaud, Gabrielle Couchy, et al.
Gut (2024) Vol. 73, Iss. 11, pp. 1870-1882
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top